$Portola制药(PTLA)$ "they expect a full commercial launch of the Gen2 product (recall that the company has secured almost two years of Gen2 supply) to begin in January,

likely in the latter part of the month as it will probably require a couple of
weeks to complete the packaging and labeling of the products. In addition,
the company expects to add to its current sales force of 78 reps by an
additional 40 reps, who will likely take 6-8 weeks to be fully on-board. As
such, we expect a slower Andexxa uptake in 1Q19, followed by a continued

ramp-up through 2019." by Credit Suisse